Related by context. All words. (Click for frequent words.) 73 placebo dexamethasone 72 malignancy HCM 71 infliximab monotherapy 70 FOLFIRI alone 70 receiving XGEVA 70 plus methotrexate 70 achieved ACR# 70 8mg/kg 70 FOLFOX4 alone 69 prednisone prednisolone plus 69 oxycodone CR 68 mitoxantrone plus 68 ACTEMRA TM 68 plus prednisone 68 mcg kg REBETOL 68 FluCAM arm 68 plus prednisone prednisolone 68 FUSILEV enhances 67 PROCTOCORT ® Suppository Hydrocortisone 67 plus dexamethasone 67 FOLFOX4 67 mg kg belimumab 67 moderate renal impairment 67 oxycodone IR 67 urinary N telopeptide 67 lopinavir r arm 67 Folfox 67 interferon alfa 2a 67 plus OBT 67 alfa 2a 66 hypertrichosis occurred 66 naïve HCV 66 Amgen Neulasta R 66 TO AVOID PREGNANCY WHILE 66 stage IIIb IV 66 mg TID 66 Acetate Rectal Suppositories 66 neutropenia dehydration dyspnea 66 receiving INTRON 66 5-FU/LV 66 deep venous thromboses 66 Flu Cy 66 TAXUS p value 66 tapentadol IR 66 relapsed MM 66 mcg QD 66 metabolic alkalosis 66 myelodysplastic myeloproliferative diseases 66 morphometric vertebral fractures 65 generalized edema 65 Ribavirin causes 65 receiving VICTRELIS 65 metastatic colorectal carcinoma 65 certolizumab 65 vitreous floaters 65 non splenectomized 65 4mg/kg 65 -#.# log# 65 myocardial infarction ventricular fibrillation 65 brand ciclesonide HFA 65 included exfoliative dermatitis 65 Mg Uk 65 comparator arm 65 IFL chemotherapy regimen 65 nicardipine 65 mg QD 65 adjunctive placebo 65 FEMALES SHOULD BE ADVISED 65 Mg Usa 65 3mg/kg 65 daunorubicin 65 Peg IFN 65 Nasdaq adv dec 65 BCG refractory carcinoma 65 leucopenia 65 p = NS 65 hypophosphatemia 65 5 FU leucovorin 64 #.#mg/dL 64 -#.# mg dL [001] 64 EARNINGS IN RETROSPECT 64 Platinol ® cisplatin 64 LOW PRICE STOCK 64 dose dexamethasone 64 Ovitrelle R Serostim 64 XIENCE V vs. 64 dose pravastatin 64 tirofiban 64 splenectomized 64 plus aztreonam 64 #mg BID [001] 64 humanized interleukin 6 64 dalteparin 64 FluCAM 64 HDL glucose 64 log# IU mL 64 vincristine doxorubicin 64 PLX STROKE targeting 64 linaclotide treated 64 discontinuations due 64 doxorubicin cyclophosphamide 64 receiving highly emetogenic 64 low dose Iluvien 64 PASI scores 64 including cyclosporine methotrexate 64 dizziness nausea diarrhea 64 chlorambucil 64 ® bortezomib 64 % CI #.#-#.# [005] 64 melphalan prednisone 64 refractory chronic lymphocytic 64 alanine aminotransferase 64 anthracycline taxane 64 folinic acid 64 mcg albinterferon alfa 2b 64 unresectable HCC 64 R sorafenib tablets 64 leukopenia 64 Annualized ROE 64 Dementia Related Psychosis 64 febrile neutropenia 64 IFN alfa 64 adjunctive ABILIFY 64 receiving prophylactic anticoagulation 64 5 Fluorouracil 64 Secondary endpoints included 64 PSA nadir 64 REMICADE monotherapy 64 steroid dexamethasone 63 serum urate 63 Salim Yusef 63 neuropathy sensory 63 + PH# 63 accompanying electrolyte abnormalities 63 abacavir lamivudine 63 FOLFOX6 63 VELCADE melphalan 63 CI #.#-#.# [001] 63 hyperphenylalaninemia HPA due 63 Cream USP 1 63 severe NCI CTC 63 cyclophosphamide doxorubicin vincristine 63 budesonide pMDI 63 plus gemcitabine 63 autoantibody positive 63 FOLFOX 63 corticosteroid dose 63 CYP#A# substrate 63 tapentadol ER 63 % Confidence Interval 63 abdominal pain abdominal discomfort 63 ARCALYST ® 63 pegylated interferon alpha 63 mg ustekinumab 63 amoxicillin clavulanate 63 fatigue asthenia 63 Thal Dex 63 Pegasys plus Copegus 63 ® lenalidomide 63 #.#/#.# mmHg [001] 63 clodronate 63 plus glimepiride 63 TO PULLBACK AFTER YESTERDAY 63 Nonresidential structures 63 R Saizen R 63 HBeAg negative patients 63 tolterodine ER 63 mcg BID 63 irinotecan doxorubicin oxaliplatin paclitaxel 63 gemcitabine cisplatin 63 hypomagnesemia 63 CIMZIA TM certolizumab pegol 63 interferon beta 1a infertility 63 HBeAg seroconversion 63 intravesical infusion therapy 63 ALT elevation 63 & s2 = 63 ritonavir boosted 63 placebo p = 63 metastatic GIST 63 CIMZIA ™ 63 systemic corticosteroid 63 incidence ≥ 63 Apidra ® 63 Hazard Ratio HR 63 Hazard Ratio 63 rimonabant #mg/day 63 CR nPR 63 ARB telmisartan 63 remarkable #,#:# contrast 63 elevated serum creatinine 63 smoldering multiple myeloma 63 ULORIC 63 Index CDAI 63 Intravitreal injections 63 R adefovir dipivoxil 63 telaprevir dosed 63 #-#-# drlg [003] 63 mg hydrochlorothiazide 62 lenalidomide Revlimid R 62 refractory NSCLC 62 TNF Tumor Necrosis Factor 62 -#.# mg dL [002] 62 lumbar spine bone 62 plus octreotide LAR 62 confidence interval #.#-#.# 62 â ‰ ¥ 62 interferon alfa 2b 62 infusional 62 irinotecan cisplatin 62 Secondary endpoints include 62 drotrecogin alfa activated 62 valsartan amlodipine 62 SPRYCEL ® 62 headache nasopharyngitis 62 cisplatin gemcitabine 62 microbiological eradication 62 Lucentis monotherapy 62 patients coinfected 62 thromboxane substance 62 glipizide plus 62 pegylated interferon alfa 2b 62 saline placebo 62 receiving golimumab 62 reduce serum phosphate 62 Peginterferon alfa 2b 62 FOLFOX6 chemotherapy regimen 62 J Shoulder Elbow 62 nadolol 62 dose cytarabine 62 #mg q8h 62 #Gy 62 J Antimicrob Chemother 62 aspirin clopidogrel 62 % CI #.#-#.# [007] 62 zoledronic acid Reclast 62 Soriatane R acitretin capsules 62 Amgen Neulasta ® 62 Zorbtive TM 62 oral hypoglycemic agent 62 lopinavir r 62 achieved sustained virologic 62 unresectable tumors 62 β blocker 62 CI -#.# 62 sUA 62 NNT = 62 potent CYP#A# inhibitors 62 octreotide LAR 62 mg BID dose 62 oral antidiabetic medication 62 vapreotide acetate 62 biologic DMARD 62 SMARTREND WATCHING FOR PULLBACK 62 active ankylosing spondylitis 62 CR CRu 62 oral clodronate 62 mild renal insufficiency 62 transaminases 62 dornase alfa 62 HBeAg positive patients 62 pegylated interferon alpha 2a 62 Soyabean Ext Bulk 62 Bearish Average Crossover 62 CTAP# 62 oral allopurinol 62 CIMZIA TM 62 microgram kg 62 Fludara 62 echinacea tablets 62 urate lowering therapy 62 By JENNIFER LEARN 62 severe neutropenia 62 weekly subcutaneous injections 62 Pegasys ® 62 achieved CCyR 62 ecchymosis 62 achieved mucosal healing 62 aspartate aminotransferase 62 pamidronate 62 interferon ribavirin 62 plus fludarabine 62 PREZISTA r arm 62 REYATAZ r arm 62 ROATE 62 pegylated interferon peg IFN 62 transaminase elevations 62 salmeterol fluticasone 62 NOTES Applicable 62 % CI #.#-#.# [003] 61 HBeAg negative 61 baseline neutrophil counts 61 evaluating tivozanib 61 Jingle spina bifida 61 haematologic 61 ritonavir boosted atazanavir 61 TO POTENTIALLY REBOUND AFTER 61 bone marrow reticulin 61 imipenem 61 receiving immunosuppressive therapy 61 pegIFN 61 biochemical relapse 61 #mg/day [002] 61 administering XIFAXAN 61 carboplatin chemotherapy 61 Technical Downtrend Reversal 61 FOLFIRI 61 ACR# ACR# 61 FROVA 61 bevacizumab Avastin R 61 arterial thromboembolic events 61 doxazosin 61 Naive Patients 61 decompensated liver disease 61 MDS MPD 61 oral levofloxacin 61 -#.# log# copies mL 61 hip BMD 61 benazepril 61 tamoxifen Nolvadex ® 61 mg kg Hematide 61 Taxus Stent 61 MCyR 61 DOXIL ® 61 APTIVUS r 61 mL/min/#.# m2 61 locoregional recurrence 61 Peginterferon 61 mg m² 61 subtrochanteric 61 nucleoside naive 61 nasopharyngitis headache 61 placebo fluoxetine 61 CCyR 61 TAXUS Express Stent 61 receiving FUSILEV 61 R# #mg BID 61 somatostatin analog 61 pulmonary exacerbations 61 R lenalidomide 61 MARTEN TRANSPORT LTD 61 Gets Bearish Confirmation 61 severe renal impairment 61 JANUS CAPITAL 61 pegylated interferon alfa 61 primary hypercholesterolemia 61 developing Bicifadine serotonin 61 sorafenib tablets 61 nodular partial response 61 receiving ISENTRESS 61 Pharmacokinetic parameters 61 aldosterone antagonist 61 Median progression 61 0 document.write 61 cyclophosphamide methotrexate 61 TMP SMX 61 dapagliflozin plus 61 CI #.#-#.# [002] 61 ATACAND 61 lumbar spine BMD 61 IIIa inhibitor 61 placebo Hazard Ratio 61 baseline serum creatinine 61 denosumab subcutaneously every 61 serum phosphorous 61 dexamethasone Decadron 61 #mg BID [003] 61 aminotransferase elevations greater 61 ord = + krdDartOrd 61 mg BID 61 Oral Fingolimod 61 ergot derivatives 61 anemia hemoglobin 61 ribavirin therapy 61 Pegasys peginterferon alfa 2a 61 PROCTOCORT R 61 mg qd 61 benzoic acid hyoscyamine sulfate 61 COMBIVIR 61 TURBT 61 primidone 61 P = .# 61 interferon alfa 61 Keeps outperform 61 Aptivus ® 61 pegylated IFN 61 equi analgesic doses 61 hypokalemia 61 CYP#A# CYP#D# 61 methotrexate monotherapy 61 severely active polyarticular 61 BARACLUDE ® 61 Relapsed Refractory 61 intravenous drip dangling 61 Abrupt discontinuation 61 severe exacerbations 61 echocardiographic parameters 61 mg + GLY 61 ug dose 61 hematologic toxicity 61 postoperative chemotherapy 61 g trans fats 61 oral diclofenac 61 x ULN 61 Median PFS 61 aspirin heparin 60 SGPT 60 EARNINGS HINDSIGHT 60 lispro 60 AST ALT 60 alanine aminotransferase ALT 60 fluticasone salmeterol 60 imiquimod cream 60 DOXIL 60 carboplatin paclitaxel 60 SET TO POSSIBLY REBOUND 60 Hypocalcemia 60 opioid naive 60 Known hypersensitivity 60 metabolic disorders Saizen R 60 ADCS CGIC 60 Kla Tencor KLAC 60 Electro Rent NASDAQ ELRC 60 peginterferon alfa 2a 60 galiximab 60 Q2W 60 hepatic metastases 60 Doxil ® 60 cyclophosphamide chemotherapy 60 Danazol 60 neutrophil counts 60 metformin monotherapy 60 http:/events.fai.org 60 bone marrow reticulin deposition 60 aspartate aminotransferase AST 60 capecitabine Xeloda 60 tiotropium bromide 60 rosuvastatin #mg 60 left ventricular systolic 60 mg q#h 60 squamous histology 60 IMiDs ® compound 60 binary restenosis 60 Xeloda ® 60 RBC transfusions 60 inflammatory acne 60 ribavirin RBV 60 abdominal computed tomography 60 ® DS methenamine 60 erlotinib Tarceva ® 60 recurrent genital herpes 60 thiazide diuretic 60 Fasting blood glucose 60 ANCA associated 60 KRAS mutations occur 60 low dose cytarabine 60 plus MTX 60 Medcath NASDAQ MDTH 60 achieving hemostasis 60 azilsartan medoxomil 60 mU liter 60 Vitrasert R 60 CHOP chemotherapy 60 neutropaenia 60 plus COPEGUS 60 glomerular filtration 60 Emtriva Viread 60 CRp 60 Myelosuppression 60 preintervention 60 plus GP IIb 60 weekly CSBMs 60 PRN FDA Approves 60 docetaxel chemotherapy 60 relapsed refractory multiple myeloma 60 progression TTP 60 cisplatin chemotherapy 60 PREZISTA ritonavir 60 #mg/day [001] 60 pooled comparator 60 R metformin Concor 60 PSADT 60 #mg/m# [001] 60 Alkeran 60 recurrent VTE 60 adalimumab Humira 60 MoxDuo TM IR 60 rFSH 60 mycophenolic acid 60 nasopharyngitis 60 nitroprusside 60 induced macular edema 60 CsA 60 severe hypersensitivity reactions 60 CorVue ™ 60 HES CEL 60 NAVISTAR R 60 Intravitreal 60 via intradermal injections 60 radiotherapy RT 60 Complicated Skin 60 HIV coinfected 60 Sees FY# revs 60 intravenous bolus 60 concomitant antibiotics 60 Cell Mol Physiol 60 alpha interferons 60 zolmitriptan 60 STELARA ® 60 Free Survival PFS 60 macrolide antibiotic 60 CK # administered 60 Recap TOR 60 ArteFill persisted 60 cyclophosphamide AC 60 prednisone CHOP 60 chemotherapy FOLFOX 60 XELOX 60 PREZISTA r 60 mcg Albuferon 60 KRAS mutant tumors 60 pT3 60 PDP MLR 60 See CONTRAINDICATIONS 60 progressive dyspnea 60 essential thrombocythemia ET 60 phenyl salicylate methylene blue 60 ACR ReTakaful SEA 60 Engerix B 60 mmHg diastolic 60 desvenlafaxine succinate 60 affective psychosis 60 creatinine clearance 60 Semicondtr 60 lymphopenia 60 mg eq 60 median PFS 60 glycosylated hemoglobin levels 60 LEXIVA r 60 cGy 60 pill containing benazepril 60 bleeding pallor 60 unfractionated heparin UFH 60 Breast conserving 60 exocrine pancreatic insufficiency EPI 60 peripheral neuropathy NEC 60 q#h 60 Host Disease 60 μg doses 60 left ventricular diastolic 60 Bronchopulmonary Dysplasia 60 prokinetic agent 60 unresectable Stage III 60 BENICAR HCT 60 mEq L 60 NATRECOR R 60 intravesical therapy 60 induce orthostatic hypotension 60 pulmonary capillary wedge 60 CYT# potent vascular disrupting 60 mg simvastatin 60 REBOUND IN SHARES 60 Clinically significant 59 R LAV 59 #-#-# drlg [004] 59 esophageal candidiasis 59 rimonabant #mg 59 #-#,# mg 59 del 5q MDS 59 mm Hg diastolic 59 Cytogen marketed 59 ETF VTV PriceWatch 59 #mg QD [002] 59 moderate hepatic impairment 59 ALN HPN 59 titrated glipizide plus 59 CTAP# Capsules 59 Off Magazines 59 ACR# response 59 advanced hepatocellular carcinoma 59 hydroxymethyl coenzyme 59 postoperative inflammation 59 dose colchicine 59 baseline LDH 59 hepatorenal syndrome 59 aminotransferases 59 investigational saxagliptin 59 azathioprine 59 pharmacologically active isomer 59 TNF antagonist 59 thrombosis embolism 59 -#.# USD JPY [001] 59 NPH insulin 59 definite stent thrombosis 59 metformin IR 59 Erythropoietic therapies may 59 pegylated liposomal doxorubicin 59 idiopathic thrombocytopenic purpura ITP 59 calculated creatinine clearance 59 serum aminotransferase levels 59 Partial Response 59 teriflunomide 59 CrCl 59 partial remissions 59 Submitted Pursuant 59 TNF alpha antagonist 59 TO POTENTIALLY PULLBACK AFTER 59 reports Q3 adj 59 5 fluorouracil leucovorin 59 antithymocyte globulin 59 basal bolus regimen 59 clobetasol propionate Foam 59 recurrent glioblastoma multiforme 59 #mg/m# [002] 59 Global Nonlife Insurance 59 tamsulosin 59 RLAI 59 TO PULLBACK AFTER GAINING 59 cytarabine daunorubicin 59 intravenous bisphosphonates 59 PEGINTRON TM 59 mg Lucentis 59 Operative mortality 59 permanently discontinue Vectibix 59 Lupuzor ™ 59 tumor lysis syndrome 59 % miconazole nitrate 59 GOUT 59 highly emetogenic 59 myopathy rhabdomyolysis 59 Rate ORR 59 colorectal pancreatic 59 DMARDS 59 CHANGE WEEKLY CHANGE 59 PEGylated anti 59 glycoprotein IIb IIIa inhibitor 59 dacarbazine 59 prednisone prednisolone 59 variceal hemorrhage 59 IMiDs 59 rheumatoid arthritis RA psoriatic 59 topical gel formulation 59 FOSRENOL ® 59 #mg QD [001] 59 underwent resection 59 triglyceride concentrations 59 postmenopausal osteoporotic women 59 lenalidomide Revlimid ® 59 WYNDHAM WORLDWIDE 59 QTcF 59 mycophenolate mofetil 59 nonvertebral fractures 59 #,# BID PRICE 59 demonstrated clinically meaningful 59 dacarbazine chemotherapy 59 hematological parameters 59 overt nephropathy 59 oral rivaroxaban 59 Bullish Average Crossover 59 BUPHENYL R sodium phenylbutyrate 59 Vidaza ® 59 palifermin 59 microbiologically evaluable 59 tumors GIST 59 RANK Ligand inhibitor 59 patients evaluable 59 Another Frenchwoman Veronique 59 piotr.skolimowski @ thomson.com 59 radiochemotherapy 59 #mg #mg #mg [003] 59 hypercalcemia 59 CANCIDAS 59 Navelbine 59 vaginal progesterone gel 59 SMARTREND WATCHING FOR 59 CHEAP ONLINE PHARMACY LOW 59 lispro alone 59 PRICE GREAT DISCOUNT FREE 59 serologically active systemic lupus 59 mg/m2 dose 59 anthracycline containing 59 acetonide FA 59 Meets Primary Endpoint 59 Bullish Technical Alert 59 complete cytogenetic response 59 placebo PBO 59 visilizumab 59 EGRIFTA TM tesamorelin 59 preoperative chemotherapy 59 Inventory BPI 59 DETECTS BEARISH HARAMI PATTERN 59 OF THALIDOMIDE 59 VANTAS ® 59 idraparinux 59 HBeAg + 59 Tiuxetan 59 #.#g/day 59 EGRIFTA ™ tesamorelin 59 trimethoprim sulfamethoxazole 59 DAS# CRP 59 prolonged cytopenias 59 μg dose 59 adefovir treated 59 Viread Emtriva Sustiva 59 confidence interval CI 59 HMG CoA reductase inhibitors 59 CYPHER Stent 59 tipranavir r 59 serum magnesium 59 locoregional 59 AAG geldanamycin analog 59 chemoradiation therapy 59 assessing T DM1 59 Eur Arch 59 neutrophil count 59 MACCE 59 systemic hypotension 59 ALT flares 59 IIIa inhibitors 59 Raptiva r 59 debulking surgery 59 advanced adenomas 59 tablets #:#:# 59 NMIBC 59 Navelbine ® 59 peginterferon alfa 59 oblimersen 59 irbesartan 59 elevated transaminases 59 EGFr expressing mCRC 59 serum triglyceride levels 59 infusional 5-FU/LV 59 SSRI SNRI 59 Warfarin Coumadin 59 quetiapine risperidone 59 mcg doses 59 MAGE A3 ASCI 59 XIENCE V PROMUS Stent 59 xanthine oxidase inhibitor 59 aneurysms AAA 59 LDL triglycerides 59 SPANISH ROUNDUP 59 Pharmacokinetics PK 58 biologic antibody 58 clopidogrel Plavix 58 rilonacept Injection 58 IOP lowering 58 achieved PASI 58 dacarbazine DTIC 58 Left Ventricular Ejection Fraction 58 transaminase elevation 58 amprenavir 58 familial amyloidotic polyneuropathy FAP 58 intermittent dosing 58 laboratory abnormalities 58 golimumab CNTO 58 herpetic keratitis 58 stable angina pectoris 58 mcg mL 58 HUMIRA achieved PASI 58 Maintained Buy 58 Peginterferon alfa 2a 58 fullyear outturn represents 58 insulin sulfonylureas 58 basiliximab 58 Skin sterol 58 inhaled budesonide 58 hemoglobin A1c HbA1c 58 jana.mlcochova @ thomson.com 58 Index CDAI score 58 lenalidomide dexamethasone 58 ropivacaine 58 Capecitabine 58 doxorubicin HCl liposome injection 58 cardiac perfusion 58 ARCOXIA 58 CHEAP ONLINE PHARMACY BEST 58 Zevalin R Ibritumomab 58 Warner Chilcott Actonel 58 mg p = 58 5FU 58 mm Stent 58 Letairis ambrisentan 58 J Am Acad 58 mL/min/#.# m 2 58 baseline HbA1c 58 cytogenetic response 58 FOLPI 58 waehrend der Boerse 58 Adjusted EBITDAR margin 58 vincristine adriamycin 58 novel emulsion formulation 58 Scale EDSS 58 cytopenias 58 achieve sustained virologic 58 Repliform R revenues 58 dasatinib Sprycel 58 Diovan Exforge Tekturna Zelnorm 58 EGFR mutation positive 58 primary immunodeficiency PI 58 VaD 58 NOXAFIL Oral Suspension 58 FORT HOOD RAMPAGE 58 glulisine 58 plus dacarbazine 58 cerebral somatic oximeter 58 bivalirudin monotherapy 58 glycated hemoglobin HbA1c 58 receiving CIMZIA #mg 58 tinidazole 58 By ANNA LIZA 58 noninvasive outpatient 58 0 document.write sline 58 obstructive CAD 58 Average Stockholders Equity 58 R bisoprolol Euthyrox 58 administered concomitantly 58 PWOD 58 metastatic malignant 58 Green Party Grune 58 pCR 58 J Am Coll 58 Peginterferon Alfa 2a 58 mg Proellex 58 tibiofemoral 58 annualized relapse 58 log# copies mL 58 XIENCE V demonstrated 58 purpura ITP 58 Active Trader DARTs 58 erlotinib Tarceva R 58 dimeglumine 58 TEAEs 58 virologically suppressed 58 elevated ALT 58 Euro Libor #.# 58 shareholders equity ROAE 58 rituximab refractory 58 dasatinib Sprycel ® 58 pioglitazone HCl 58 TAXOTERE R 58 placebo p 58 Median survival 58 methotrexate MTX 58 rheumatoid arthritis osteoarthritis ankylosing 58 insulin glulisine 58 liver histology 58 PegIFN 58 strategies KPIs metrics 58 metformin sulfonylurea 58 oral vancomycin 58 lopinavir ritonavir Kaletra 58 By Scott RobertsonPublished 58 Recap LAA 58 IN PATIENTS WITH 58 Platinol ® 58 Recap OAK 58 intravitreal injections 58 oral chemotherapeutic agent 58 pegylated alpha interferon 58 Oral Suspension Oral Suspension 58 papillary renal cell carcinoma 58 Technical Uptrend Reversal 58 ALIMTA cisplatin 58 trastuzumab Herceptin R 58 Montgomery Asberg Depression 58 Hamilton Anxiety Scale 58 peg IFN 58 non menstrual pelvic 58 Lovenox enoxaparin sodium 58 BY SHANNON COLAVECCHIO 58 TTF Therapy 58 LEICA DC VARIO ELMAR 58 + Hanzo 58 sirolimus eluting stents 58 adriamycin 58 tyrosine kinase inhibitor TKI 58 Moving Average Crossover Alert 58 -#.# ± [002] 58 peripheral edema 58 oxymorphone ER 58 By Corinna PetryPublished 58 allogeneic HSCT 58 TNF antagonists 58 relapsed myeloma 58 Reiterates outperform 58 ug kg 58 6 Mcf 1bbl 58 colorectal liver metastases 58 cells uL 58 xi unanticipated 58 EUFLEXXA R 58 AFTER YESTERDAY 'S DECLINE 58 evaluable 58 gp# vaccine 58 miconazole 58 reports Q4 adj 58 atorvastatin #mg 58 bendamustine ifosfamide 58 serum HBV DNA 58 WBRT plus 58 LEO Declares Dividend 58 Consensus +#.# 58 events AEs 58 PREZISTA rtv 58 0 Thumbs Up 58 SYKES Enterprises NASDAQ SYKE 58 umol L 58 hyperplasia BPH 58 cytogenetic analyzes 58 bacillus Calmette Guerin 58 Herpes infections 58 PEGylated Fab fragment 58 sUA levels 58 minimally symptomatic metastatic castrate 58 Ceplene/IL-2 58 NR2B selective 58 proctitis 58 intracranial atherosclerosis 58 HBsAg positive 58 baminercept 58 mitoxantrone 58 Soft Tissue Sarcoma 58 anagrelide 58 TMC# r 58 pegylated interferon alfa 2a 58 MARRIOTT REVENUES totaled 58 duration mediaQueryString 58 zonisamide SR 58 sustained virological response 58 antiplatelet medications 58 antiretroviral naïve 58 CPI NYSE CPY 58 known sulfonamide allergy 58 Hycamtin ® 58 lopinavir ritonavir plus 58 prospectively stratified 58 OPANA franchise 58 Adjuvant Treatment 58 hormone receptor negative 58 Astec Industries NASDAQ ASTE 58 ALT normalization 58 ribavirin USP 58 colorectal adenoma 58 lymphocytosis 58 relapsed Acute Myeloid 58 triglyceride TG 58 nadroparin 58 stomatitis 58 Carotid endarterectomy 58 Neutropenia 58 Losers outnumbered winners 58 Omnova Solutions NYSE OMN 58 metastatic pancreatic 58 Phe restricted diet 58 liposomal amphotericin B 58 mcg linaclotide 58 mucosal healing 58 oral nucleoside analogue 58 somatropin Kuvan R 58 Levoleucovorin 58 XS# INTEREST AMT 58 Viread Emtriva 58 NEVO ™ 58 unfavorable cytogenetics 58 paresthesias 58 hemoglobin A1c levels 58 ® emtricitabine 58 Patients Treated With 58 Medoxomil 58 pegaptanib 58 Atypical Hemolytic Uremic Syndrome 58 aldosterone antagonists 58 NOLVADEX 58 APTIVUS R 58 Reclast zoledronic acid 58 resistant hormone refractory 58 phonophobia 58 mycophenolate mofetil MMF 58 unformulated vaccine 58 fluorouracil 58 paclitaxel Taxol ® 58 grade cervical intraepithelial 58 bortezomib refractory 58 glycoprotein IIb IIIa inhibitors 58 Pred Forte 58 Copegus ® 58 lymphocyte count 58 sorafenib Nexavar ® 58 normal ULN 58 ps :# 58 Primary endpoints 58 rizatriptan 58 specific alkaline phosphatase 58 histologic subtype 58 RPC RES 58 tobramycin inhalation solution 58 Yellow Ex Kandla 58 ACR# responses